AC-Gen Reading Life
Valladolid
About AC-Gen Reading Life
AC-Gen Reading Life is a Biotech company incorporating the latest technology for DNA reading enabling Next-generation Sequencing for medical use. AC-Gen Reading Life in a Biotech company focus on the biomedical sector. They offer Health specialists solutions for prevention, diagnosis and treatment of hereditary diseases. Their goal is to improve the health and quality of life of those individuals affected and their families. AC-Gen Reading Life uses Next-generation sequencing technology (NGS) based on semiconductor chips for the detection of mutations associated to recurrent appearance of a disease in members of the same family. AC-Gen Reading Life brings genomic analyses toward clinical utility providing accurate information about the mutations detected. Their report reflects the probability of occurrence of the disease as well as prevention and treatment measures to promote the best clinical decisions based on available scientific knowledge.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $39.1K
- Last round: Grant (Dec 2011)
- Website: ac-gen.com
- Phone: (+34) 983 016 257
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/ac-gen-reading-life-3472053 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.